| Evolution of cancer pharmacological treatments at the turn of the third millennium L Falzone, S Salomone, M Libra Frontiers in pharmacology 9, 1300, 2018 | 725 | 2018 |
| Cutaneous melanoma: From pathogenesis to therapy GC Leonardi, L Falzone, R Salemi, A Zanghì, DA Spandidos, ... International journal of oncology 52 (4), 1071-1080, 2018 | 583 | 2018 |
| Gut microbiota and cancer: from pathogenesis to therapy S Vivarelli, R Salemi, S Candido, L Falzone, M Santagati, S Stefani, ... Cancers 11 (1), 38, 2019 | 417 | 2019 |
| Current and future trends on diagnosis and prognosis of glioblastoma: from molecular biology to proteomics AS Silantyev, L Falzone, M Libra, OI Gurina, KS Kardashova, ... Cells 8 (8), 863, 2019 | 179 | 2019 |
| Sensitivity assessment of droplet digital PCR for SARS-CoV-2 detection L Falzone, N Musso, G Gattuso, D Bongiorno, CI Palermo, G Scalia, ... International journal of molecular medicine 46 (3), 957-964, 2020 | 177 | 2020 |
| Current perspectives in cancer immunotherapy T Christofi, S Baritaki, L Falzone, M Libra, A Zaravinos Cancers 11 (10), 1472, 2019 | 171 | 2019 |
| SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19 A Tsatsakis, D Calina, L Falzone, D Petrakis, R Mitrut, V Siokas, M Pennisi, ... Food and Chemical Toxicology 146, 111769, 2020 | 165 | 2020 |
| Integrated analysis of colorectal cancer microRNA datasets: Identification of microRNAs associated with tumor development L Falzone, L Scola, A Zanghì, A Biondi, A Di Cataldo, M Libra, S Candido Aging (Albany NY) 10 (5), 1000, 2018 | 158 | 2018 |
| Current and innovative methods for the diagnosis of COVID‑19 infection L Falzone, G Gattuso, A Tsatsakis, DA Spandidos, M Libra International journal of molecular medicine 47 (6), 1-23, 2021 | 145 | 2021 |
| SARS-CoV-2 and the nervous system: from clinical features to molecular mechanisms M Pennisi, G Lanza, L Falzone, F Fisicaro, R Ferri, R Bella International Journal of Molecular Sciences 21 (15), 5475, 2020 | 132 | 2020 |
| Occupational exposure to carcinogens: Benzene, pesticides and fibers L Falzone, A Marconi, C Loreto, S Franco, DA Spandidos, M Libra Molecular medicine reports 14 (5), 4467-4474, 2016 | 109 | 2016 |
| Immunological effects of occupational exposure to lead C Fenga, S Gangemi, V Di Salvatore, L Falzone, M Libra Molecular medicine reports 15 (5), 3355-3360, 2017 | 108 | 2017 |
| Lactobacillus rhamnosus GG: An Overview to Explore the Rationale of Its Use in Cancer GL Banna, F Torino, F Marletta, M Santagati, R Salemi, E Cannarozzo, ... Frontiers in pharmacology 8, 603, 2017 | 105 | 2017 |
| Identification of novel MicroRNAs and their diagnostic and prognostic significance in oral cancer L Falzone, G Lupo, GRM La Rosa, S Crimi, CD Anfuso, R Salemi, ... Cancers 11 (5), 610, 2019 | 99 | 2019 |
| Cutaneous melanoma and the immunotherapy revolution GC Leonardi, S Candido, L Falzone, DA Spandidos, M Libra International journal of oncology 57 (3), 609-618, 2020 | 95 | 2020 |
| Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells JA McCubrey, TL Fitzgerald, LV Yang, K Lertpiriyapong, LS Steelman, ... Oncotarget 8 (8), 14221, 2017 | 92 | 2017 |
| Identification of extracellular vesicles and characterization of miRNA expression profiles in human blastocoel fluid R Battaglia, S Palini, ME Vento, A La Ferlita, MJ Lo Faro, E Caroppo, ... Scientific reports 9 (1), 84, 2019 | 87 | 2019 |
| Prognostic significance of deregulated microRNAs in uveal melanomas L Falzone, GL Romano, R Salemi, C Bucolo, B Tomasello, G Lupo, ... Molecular medicine reports 19 (4), 2599-2610, 2019 | 86 | 2019 |
| Functional roles of matrix metalloproteinases and their inhibitors in melanoma S Napoli, C Scuderi, G Gattuso, V Di Bella, S Candido, MS Basile, M Libra, ... Cells 9 (5), 1151, 2020 | 83 | 2020 |
| Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer L Falzone, S Candido, R Salemi, MS Basile, A Scalisi, JA McCubrey, ... Oncotarget 7 (45), 72758, 2016 | 80 | 2016 |
